Skip to main content

Azacitidine Injection

Last Updated: December 14, 2022
Status: Current

Products Affected - Description
    • Azacitidine lyophilized powder for injection, Cipla USA, 100 mg, vial, 1 count, NDC 69097-0805-40
    • Azacitidine lyophilized powder for injection, Mylan Institutional (Viatris), 100 mg, vial, 1 count, NDC 67457-0254-30 - discontinued
    • Azacitidine lyophilized powder for injection, Wockhardt USA, 100 mg, vial, 1 count, NDC 64679-0096-01 - discontinued
Reason for the Shortage
    • Accord had azacitidine on back order due to a shortage of the raw ingredient.
    • Armas has azacitidine injection available.
    • Cipla does not expect more supply in the near future.
    • Celgene (now part of Bristol-Myers Squibb) had Vidaza on shortage due to increased demand.
    • Dr. Reddy's has azacitidine injection available.
    • Fresenius Kabi has azacitidine injection available.
    • Hikma has azacitidine injection available.
    • Meitheal has azacitidine injection available.
    • Sandoz has azacitidine injection available.
    • Viatris discontinued azacitidine in September 2022.
    • Wockhardt discontinued azacitidine in mid-2022.
Available Products
    • Vidaza lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, 1 count, NDC 59572-0102-01
    • Azacitidine lyophilized powder for injection, Accord, 100 mg, vial, 1 count, NDC 16729-0306-10
    • Azacitidine lyophilized powder for injection, Armas Pharmaceuticals, 100 mg, vial, 1 count, NDC 72485-0201-01
    • Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0305-62
    • Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0143-62
    • Azacitidine lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 1 count, NDC 63323-0771-39
    • Azacitidine lyophilized powder for injection, Hikma, 100 mg, vial, 1 count, NDC 00143-9606-01
    • Azacitidine lyophilized powder for injection, Meitheal Pharmaceuticals, 100 mg, vial, 1 count, NDC 71288-0115-30
    • Azacitidine lyophilized powder for injection, Sandoz, 100 mg, vial, 1 count, NDC 00781-3253-94

Estimated Resupply Dates

    • Most marketed presentations are available.

Updated

Updated December 14, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 2, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.